SLT Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SLT Holdings's LLY Position: Q3 2026 in Review
SLT Holdings reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $17.7K and leaving 950 shares worth $1.1M. The position accounts for 0.64% of the portfolio, ranked #41.
SLT Holdings first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.16M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- SLT Holdings held 950 shares of Eli Lilly worth $1.1M as of Q3 2026.
- SLT Holdings sold 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
- Eli Lilly made up 0.64% of SLT Holdings's portfolio in Q3 2026, its #41 holding.
- SLT Holdings first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
- SLT Holdings's Eli Lilly position peaked at $1.16M in Q2 2026.
- 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.